 |
|
|
Nurofen Migraine Pain (pack of 12 tablets) |
Nurofen Migraine Pain is for the effective relief of migraine and headache pain.
- Each tablet contains 342mg of the active ingredient ibuprofen
- Nurofen Migraine Pain contains Ibuprofen Lysine, which belongs to a group of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs provide relief by changing the body's response to pain, swelling and high temperature.
- Also contains: Povidone, sodium starch glycollate, magnesium stearate, hypromellose, talc, Opaspray White M-1-7111 B (contains hypromellose and titanium dioxide) and Opacode Black S-1-8152HV (contains iron oxide, shellac, soya lecithin and antifoam DC1510).
.
IMPORTANT
You should not take NUROFEN Migraine Pain if:
You have had an allergic reaction to aspirin, ibuprofen or any of the other ingredients listed above; You have had a worsening of asthma, allergic rash or itchy, runny nose when taking similar medicines; You have or have ever had a stomach ulcer.
Ask your doctor or pharmacist before taking Nurofen Migarine Pain if:
You are asthmatic, or suffering from heart, liver or kidney disease; You are taking regular medication, especially medicine for high blood pressure eg. water tablets (diuretics), or anti-coagulants (blood thinners), Lithium or Methotrexate; You are pregnant or breast feeding.
Not for children under 12 years of age.
Product information leaflet:
http://emc.medicines.org.uk/medicine/20099/SPC/Nurofen Express 342mg Caplets/
|
|
Ibuprofen 200 mg ( as ibuprofen Lysine )
Film-coated tablet. White, capsule - shaped tablet, printed with an identifying logo in black on one face
For the relief of headache and migraine pain.
|
|
Adults and children over 12 years: Initial dose, one or two tablets, then if necessary, one or two tablets every four hours. Do not exceed six tablets in any 24 hours. Leave at least 4 hours between doses.
For oral administration. To be taken with water.
Not recommended for children under 12 years of age.
Elderly: No special dosage modifications are required.
|
|
Hypersensitivity to any of the constituents, aspirin or other non steroidal anti-inflammatory drugs (NSAIDs).
Patients with existing, or a history of peptic ulceration.
Patients with a history of bronchospasm, rhinitis or urticaria associated with aspirin or other NSAIDs.
Severe heart failure
|
|
Caution is required in patients with renal, cardiac or hepatic impairment. In patients with renal impairment, renal function should be monitored since it may deteriorate following the use of any NSAID.
Bronchospasm may be precipitated in patients suffering from, or with a previous history of bronchial asthma or allergic disease.
The elderly are at increased risk of consequences of the serious consequence of adverse reactions.
Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see GI and cardiovascular risks below).
Caution (discussion with doctor or pharmacist) is required prior to starting treatment in patients with a history of hypertension and/or heart failure as fluid retention, hypertension and oedema have been reported in association with NSAID therapy.
Cardiovascular and cerebrovascular effects
Clinical trial and epidemiological data suggest that use of ibuprofen, particularly at high doses (2400mg daily) and in long-term treatment may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke). Overall, epidemiological studies do not suggest that low dose ibuprofen (e.g. 1200mg daily) is associated with an increased risk of myocardial infarction.
|
|
|
